The major medical regulator of the European Union, European Medicines Agency (EMA), supported on Thursday two developed COVID-19 vaccine booster shots that target Omicron and its subvariants.
The decision came as Europe is expecting a rise in Coronavirus infections ahead winter.
Currently, there are two developed boosters against Omicron: Moderna and Pfizer. Both developed vaccines are effective against the original version of the virus detected in China in 2020 as well.
EMA’s recommendation is to approve the vaccines for people who aged 12 years old and above who are already fully vaccinated.
The final approval by the European Commission is expected to be provided shortly after EMA’s recommendation.
Moreover, both Pfizer and Moderna are expected to start supplying EU countries with the shots in a few days.
Two weeks ago, the UK approved the first developed Coronavirus vaccine that targets Omicron and its latest subvariants to be the first country in the world to take such an action.
The UK medicines regulator (MHRA) authorized the bivalent vaccine made by Moderna (MRNA.O) doses as booster shots for adults, adding that the vaccine showed “a strong immune response” against both Omicron (BA.1) and the original variant of the virus.
The upgraded shots developed by Moderna showed a strong response to the Omicron variant, better than the previous version of the vaccine, a study published last June showed.
The study was conducted by the company and targeted using the developed drug as booster shots against Coronavirus in the upcoming weeks.
Moderna’s new shot is not only directed to Omicron but also to the original strains of the virus.